Dr. King's SafeCare Rx Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000624, NDC 57955-0006-2

Microbial contamination

Recall #: D-0858-2019
Affected scope: 753 bottles
Initiated: July 20, 2018

Compiled from official public sources by the publisher. · Updated September 2026

King Bio Inc. recalled Dr. King's SafeCare Rx Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr… - a critical-severity action.

Dr. King's SafeCare Rx Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr… was recalled by King Bio Inc. in March 20, 2019. Reason: Microbial contamination. Check the official notice for the remedy. Verify recall #D-0858-2019 with the FDA Drug before acting.

The recall

King Bio Inc. issued this critical-severity FDA Drug recall-Microbial contamination.

Critical
severity level: Class I
classification: March 20, 2019
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0858-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Dr. King's SafeCare Rx Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000624, NDC 57955-0006-2

Reason for recall

Microbial contamination

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Critical (Class I)
Status	Terminated
Recall number	D-0858-2019
Date reported	March 20, 2019
Date initiated	July 20, 2018
Recalling firm	King Bio Inc.
Firm location	Asheville, NC
Affected scope	753 bottles
Distribution	U.S.A. Nationwide, Canada, and Australia.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0858-2019) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Dr. King's SafeCare Rx Menopause Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000624, NDC 57955-0006-2. Recalled by King Bio Inc.. Units affected: 753 bottles.

Why was this product recalled? ▼

Microbial contamination

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on March 20, 2019. Severity: Critical. Recall number: D-0858-2019.

Where was the recalled product distributed? ▼

Distribution: U.S.A. Nationwide, Canada, and Australia..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Critical), closest by report date among other firms and states.

HONDA 2018-2019: SERVICE BRAKES, AIR:ANTI… 2019-03-20 INTERNATIONAL 2017-2020: FUEL SYSTEM, DIE… 2019-03-20 VOLKSWAGEN 2019-2020: AIR BAGS:SIDE/WINDOW 2019-03-20 VOLVO 2018-2019: SEATS 2019-03-20

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Oxybutynin Chloride Extended-Release Tabl… 2019-03-20 Mirapex (pramipexole dihydrochloride) Tab… 2019-03-20 Gentamicin Sulfate Ophthalmic Solution, U… 2019-03-20 Oxybutynin Chloride, Extended-Release Tab… 2019-03-20

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported March 20, 2019. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026